Fiche centre
Friedrich Baur Institute
München — Germany
Essais liés2clinical trials
VilleMünchenlocalisation
PaysGermanylocalisation
SourcelocaleCSV/MySQL
Informations
centreImport ClinicalTrials.gov
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Pozelimab + Cemdisiran | Myasthénie | Phase 3 | NCT05070858 | NIMBLE — A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis | ACTIVE_NOT_RECRUITING |
| VX-670 | Myopathies | Phase 2 | NCT06926621 | A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I | ENROLLING_BY_INVITATION |